// App-Quantinova.ai

: Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure

Researchers

Presenter

  • Ahmed Ghoneem

Principal Investigators

  • Ammar W Bhatti

  • Joshua D Mitchell

  • Jennifer Liu

  • Kathleen Zhang

  • Barry Trachtenberg

  • Ashtoush Wechalekar

  • Richard Cheng

  • Suzanne J Baron

  • Anju Nohria

  • Daniel Lenihan

  • Sourbha Dani

  • Sarju Ganatra

Medical Centers

  • Kings College London, London, United Kingdom

  • University of Washington, Seattle, WA

  • WU, Saint Louis, MO

  • Houston Methodist Hospital, Houston, TX

  • Washington Univ in St. Louis, Kirkwood, MO

  • Brigham & Women's Hospital, Boston, MA

  • InternationalCardio-OncologySociety, Festus, MO

  • Memorial Sloan Kettering, New York, NY

  • Lahey Hospital and Medical Center, Burlington, MA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Amyloidosis, transthyretin-related

  • Congestive heart failure

  • Amyloid disease

Biomarkers

  • Folate Hydrolase 1

  • Transthyretin

Drug/Treatment

  • Tafamidis meglumine

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved